SNDL on Nasdaq
SNDL Inc.
SNDL Inc. is a Canadian medicinal chemicals and botanical products company based in Edmonton.2
Price unavailable
Last updated Oct 20, 2026.
Overview
Compare with Canopy Growth Corporation, Aurora Cannabis or IM Cannabis Corp., or pick any stock.
- TickerSNDL on Nasdaq2
- IndustryMedicinal Chemicals & Botanical Products2
- HeadquartersEdmonton, Canada2
- Incorporated inAlberta, Canada4
- Business address17220 Stony Plain Road Nw, Suite 101, Edmonton4
- Filer categoryLarge accelerated filer4
- Legal formAlberta Business Corporation2
- LEI984500EBVC4BEACF6F532
- StatusActive2
- LEI statusIssued and current2
- Registered address4000-421 7 AVE SW, T2P 4K9 Alberta, Canada2
- Registered withMinistry of Service Alberta, 20267162622
Financials
From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Liquor Retail brought in 38% of the revenue SNDL Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Liquor Retail | 555.3M CAD | 539.6M CAD |
| Cannabis | 365.2M CAD | 406.8M CAD |
| Cannabis Retail | 311.7M CAD | 330.2M CAD |
| Cannabis Operations | 109.5M CAD | 144.7M CAD |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue73¢687.8M CAD
- Research and development0¢489.0K CAD
- Other costs27¢251.5M CAD
- Interest1¢6.7M CAD
Out of 946.4M CAD in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending18¢12.8M CAD
- Share buybacks22¢15.3M CAD
- Kept or used elsewhere60¢42.8M CAD
Out of 70.9M CAD of cash from operations.3
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net revenue | 946.4M CAD | 920.4M CAD |
| Cost of sales | 687.8M CAD | 680.1M CAD |
| Gross profit | 258.6M CAD | 240.3M CAD |
| Investment income | 7.8M CAD | 15.6M CAD |
| Share of loss of equity-accounted investees | -3.6M CAD | -65.5M CAD |
| General and administrative | 182.2M CAD | 187.2M CAD |
| Sales and marketing | 14.6M CAD | 12.0M CAD |
| Research and development | 489.0K CAD | 346.0K CAD |
| Depreciation and amortization | 51.9M CAD | 54.2M CAD |
| Share-based compensation | 13.9M CAD | 20.0M CAD |
| Restructuring costs | 3.3M CAD | 2.7M CAD |
| Asset impairment, net | 2.6M CAD | 17.3M CAD |
| Loss on disposition of assets | 182.0K CAD | 370.0K CAD |
| Operating loss | -6.3M CAD | -103.8M CAD |
| Other expenses, net | -9.4M CAD | -1.8M CAD |
| Loss before income tax | -15.8M CAD | -105.6M CAD |
| Income tax recovery | 0 CAD | 9.4M CAD |
| Net loss | -15.8M CAD | -96.2M CAD |
| Equity-accounted investees - share of other comprehensive (loss) income | -19.2M CAD | 31.5M CAD |
| "Investments at fair value through other comprehensive income (""FVOCI"") - change in fair value" | 5.4M CAD | 1.9M CAD |
| Owners of the company | -15.8M CAD | -94.8M CAD |
| Non-controlling interest | 0 CAD | -1.4M CAD |
| Owners of the company | -29.6M CAD | -61.4M CAD |
| Non-controlling interest | 0 CAD | -1.4M CAD |
| Comprehensive loss | -29.6M CAD | -62.9M CAD |
| Basic net loss per common share attributable to owners of the Company | -0.06 CAD | -0.36 CAD |
| Diluted net loss per common share attributable to owners of the Company | -0.06 CAD | -0.36 CAD |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | 252.2M CAD | 218.4M CAD | 195.0M CAD |
| Restricted cash | 20.1M CAD | 19.8M CAD | |
| Marketable securities | 84.0K CAD | 139.0K CAD | |
| Accounts receivable | 27.6M CAD | 28.1M CAD | |
| Biological assets | 3.1M CAD | 1.2M CAD | 429.0K CAD |
| Inventory | 126.9M CAD | 127.9M CAD | |
| Prepaid expenses and deposits | 15.6M CAD | 16.9M CAD | |
| Investments | 484.0K CAD | 27.6M CAD | |
| Assets held for sale | 746.0K CAD | 19.1M CAD | |
| Net investment in subleases | 2.8M CAD | 2.8M CAD | |
| Current assets | 449.6M CAD | 461.8M CAD | |
| Long-term deposits and receivables | 4.5M CAD | 3.7M CAD | |
| Right of use assets | 138.4M CAD | 115.4M CAD | |
| Property, plant and equipment | 151.9M CAD | 145.8M CAD | |
| Net investment in subleases | 11.6M CAD | 15.4M CAD | |
| Intangible assets | 58.5M CAD | 61.3M CAD | |
| Investments | 11.6M CAD | 8.4M CAD | |
| Equity-accounted investees | 385.5M CAD | 413.1M CAD | |
| Goodwill | 124.2M CAD | 124.2M CAD | 119.3M CAD |
| Total assets | 1.3B CAD | 1.3B CAD | |
| Accounts payable and accrued liabilities | 56.7M CAD | 56.3M CAD | |
| Current lease liabilities | 35.5M CAD | 34.3M CAD | |
| Derivative warrants | 0 CAD | 26.0K CAD | |
| Current liabilities | 92.2M CAD | 90.6M CAD | |
| Lease liabilities | 134.5M CAD | 118.0M CAD | |
| Other liabilities | 8.0M CAD | 7.3M CAD | |
| Total liabilities | 234.7M CAD | 215.9M CAD | |
| Share capital | 2.3B CAD | 2.3B CAD | |
| Warrants | 306.0K CAD | 667.0K CAD | |
| Contributed surplus | 54.0M CAD | 57.2M CAD | |
| Accumulated deficit | -1.3B CAD | -1.3B CAD | |
| Accumulated other comprehensive income | 38.9M CAD | 52.8M CAD | |
| Total shareholders equity | 1.1B CAD | 1.1B CAD | |
| Total liabilities and shareholders equity | 1.3B CAD | 1.3B CAD |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | 252.2M CAD | 218.4M CAD | 195.0M CAD |
| Restricted cash | 20.1M CAD | 19.8M CAD | |
| Marketable securities | 84.0K CAD | 139.0K CAD | |
| Accounts receivable | 27.6M CAD | 28.1M CAD | |
| Biological assets | 3.1M CAD | 1.2M CAD | 429.0K CAD |
| Inventory | 126.9M CAD | 127.9M CAD | |
| Prepaid expenses and deposits | 15.6M CAD | 16.9M CAD | |
| Investments | 484.0K CAD | 27.6M CAD | |
| Assets held for sale | 746.0K CAD | 19.1M CAD | |
| Net investment in subleases | 2.8M CAD | 2.8M CAD | |
| Current assets | 449.6M CAD | 461.8M CAD | |
| Long-term deposits and receivables | 4.5M CAD | 3.7M CAD | |
| Right of use assets | 138.4M CAD | 115.4M CAD | |
| Property, plant and equipment | 151.9M CAD | 145.8M CAD | |
| Net investment in subleases | 11.6M CAD | 15.4M CAD | |
| Intangible assets | 58.5M CAD | 61.3M CAD | |
| Investments | 11.6M CAD | 8.4M CAD | |
| Equity-accounted investees | 385.5M CAD | 413.1M CAD | |
| Goodwill | 124.2M CAD | 124.2M CAD | 119.3M CAD |
| Total assets | 1.3B CAD | 1.3B CAD | |
| Accounts payable and accrued liabilities | 56.7M CAD | 56.3M CAD | |
| Current lease liabilities | 35.5M CAD | 34.3M CAD | |
| Derivative warrants | 0 CAD | 26.0K CAD | |
| Current liabilities | 92.2M CAD | 90.6M CAD | |
| Lease liabilities | 134.5M CAD | 118.0M CAD | |
| Other liabilities | 8.0M CAD | 7.3M CAD | |
| Total liabilities | 234.7M CAD | 215.9M CAD | |
| Share capital | 2.3B CAD | 2.3B CAD | |
| Warrants | 306.0K CAD | 667.0K CAD | |
| Contributed surplus | 54.0M CAD | 57.2M CAD | |
| Accumulated deficit | -1.3B CAD | -1.3B CAD | |
| Accumulated other comprehensive income | 38.9M CAD | 52.8M CAD | |
| Total shareholders equity | 1.1B CAD | 1.1B CAD | |
| Total liabilities and shareholders equity | 1.3B CAD | 1.3B CAD |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss for the period | -15.8M CAD | -96.2M CAD |
| Income tax recovery | 0 CAD | -9.4M CAD |
| Interest and fee income | -7.4M CAD | -15.6M CAD |
| Change in fair value of biological assets | -2.3M CAD | 675.0K CAD |
| Change in fair value of inventory sold | 1.3M CAD | -1.6M CAD |
| Share-based compensation | 13.9M CAD | 20.0M CAD |
| Depreciation and amortization | 56.3M CAD | 56.7M CAD |
| Loss on disposition of assets | 182.0K CAD | 370.0K CAD |
| Inventory impairment and obsolescence | 2.7M CAD | 3.7M CAD |
| Finance costs, net | 6.7M CAD | 7.2M CAD |
| Change in estimate of fair value of derivative warrants | -26.0K CAD | -4.4M CAD |
| Unrealized foreign exchange loss | 614.0K CAD | 108.0K CAD |
| Transaction costs | 0 CAD | 164.0K CAD |
| Bargain purchase gain | 0 CAD | -5.5M CAD |
| Asset impairment, net | 2.6M CAD | 17.3M CAD |
| Share of loss of equity-accounted investees | 3.6M CAD | 65.5M CAD |
| Unrealized (gain) loss on marketable securities | -378.0K CAD | 86.0K CAD |
| Additions to marketable securities | 433.0K CAD | 0 CAD |
| Income distributions from equity-accounted investees | 68.0K CAD | 10.7M CAD |
| Interest received | 7.1M CAD | 12.5M CAD |
| Change in non-cash working capital | 1.4M CAD | -7.4M CAD |
| Net cash provided by operating activities | 70.9M CAD | 54.9M CAD |
| Additions to property, plant and equipment | -12.8M CAD | -8.6M CAD |
| Additions to intangible assets | 0 CAD | -2.4M CAD |
| Additions to investments | -16.4M CAD | -36.2M CAD |
| Principal payments from investments | 27.5M CAD | 13.5M CAD |
| Proceeds from disposal of investments | 18.1M CAD | 0 CAD |
| Capital refunds from equity-accounted investees | 0 CAD | 168.0K CAD |
| Capital distributions from equity-accounted investees | 4.7M CAD | 89.8M CAD |
| Proceeds from disposal of property, plant and equipment | 813.0K CAD | 734.0K CAD |
| Acquisitions, net of cash acquired | -3.0M CAD | -39.6M CAD |
| Change in non-cash working capital | -1.4M CAD | 383.0K CAD |
| Net cash provided by investing activities | 17.5M CAD | 17.8M CAD |
| Change in restricted cash | -267.0K CAD | 76.0K CAD |
| Payments on lease liabilities, net | -39.2M CAD | -37.0M CAD |
| Repurchase of common shares | -15.3M CAD | -13.2M CAD |
| Proceeds from issuance of shares, net of costs | 0 CAD | -59.0K CAD |
| Issuance of common shares by subsidiaries | 0 CAD | 174.0K CAD |
| Change in non-cash working capital | 373.0K CAD | 621.0K CAD |
| Net cash used in financing activities | -54.5M CAD | -49.4M CAD |
| Change in cash and cash equivalents | 33.9M CAD | 23.3M CAD |
No quarter-by-quarter statement was filed.
Corporate structure
SNDL Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of SNDL Inc.
- ARMISTICE CAPITAL, LLC Filed SCHEDULE 13G/A on SNDL Inc., latest Aug 20, 2025 (2 filings since Aug 14, 2025)
- ETF MANAGERS GROUP, LLC Filed SC 13G/A on SNDL Inc., latest Feb 14, 2023 (2 filings since Aug 25, 2022)
- SNDL Inc. Edmonton, Alberta, Canada
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What SNDL Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, net | 151.9M CAD3 Dec 31, 2025 | 145.8M CAD3 Dec 31, 2024 | +4.2% |
| Operating-lease assets (leased space) | 138.4M CAD3 Dec 31, 2025 | 115.4M CAD3 Dec 31, 2024 | +19.9% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | 252.2M CAD3 Dec 31, 2025 | 218.4M CAD3 Dec 31, 2024 | +15.5% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | 124.2M CAD3 Dec 31, 2025 | 124.2M CAD3 Dec 31, 2024 | 0% |
| Intangible assets, net (excluding goodwill) | 58.5M CAD3 Dec 31, 2025 | 61.3M CAD3 Dec 31, 2024 | −4.6% |
Inventory
Former names
- Sundial Growers Inc.Apr 29, 2019 to Jul 25, 20224
Timeline
- Dec 31, 2024Founded SNDL Inc. is founded2
Calendar
Coming up
- Oct 27, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported ($0.04) a share, on Nov 4, 2025.11
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
191 filings to the SEC since October 2021: 6 annual reports, 7 large holders, 178 other. The latest 20:
- Oct 15, 20266-K EDGAR
- Oct 14, 20266-K EDGAR
- Oct 6, 20266-K EDGAR
- Sep 8, 20266-K EDGAR
- Aug 4, 20266-K EDGAR
- Jul 28, 20266-K EDGAR
- Jul 28, 20266-K EDGAR
- Jul 27, 20266-K EDGAR
- Jul 15, 20266-K EDGAR
- May 28, 20266-K EDGAR
- Apr 29, 20266-K EDGAR
- Apr 29, 20266-K EDGAR
- Apr 15, 20266-K EDGAR
- Mar 30, 20266-K EDGAR
- Mar 12, 202640-F EDGAR
- Mar 12, 20266-K EDGAR
- Feb 19, 20266-K EDGAR
- Jan 7, 20266-K EDGAR
- Dec 15, 20256-K EDGAR
- Dec 12, 2025144 EDGAR
The 191 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- ARMISTICE CAPITAL, LLCSCHEDULE 13G/A, 2 filings Aug 14, 2025 to Aug 20, 202512
- ETF MANAGERS GROUP, LLCSC 13G/A, 2 filings Aug 25, 2022 to Feb 14, 202313
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Morgan Stanley | 10,214,013 | $13.8M | 0.0% | −1,197,108 |
| Cannell Capital LLC | 8,639,381 | $11.7M | 8.1% | −121,774 |
| Tidal Investments LLC | 5,334,370 | $7.2M | 0.0% | −176,305 |
| Arrowstreet Capital, Limited Partnership | 2,357,401 | $3.2M | 0.0% | −639,022 |
| Citadel Advisors LLC | 2,165,081 | $2.9M | 0.0% | +286,969 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2,113,976 | $2.9M | 0.0% | −125,388 |
| Goldman Sachs Group Inc | 1,970,467 | $2.7M | 0.0% | +788,392 |
| Susquehanna International Group, Llp | 1,913,418 | $2.6M | 0.0% | +351,097 |
| Ewing Morris & Co. Investment Partners Ltd. | 1,481,222 | $2.0M | 1.0% | +180,000 |
| Jpmorgan Chase & Co | 1,262,553 | $1.7M | 0.0% | −135,767 |
| Jane Street Group, LLC | 1,165,093 | $1.6M | 0.0% | +841,619 |
| Renaissance Technologies LLC | 1,051,792 | $1.4M | 0.0% | +449,567 |
| Man Group plc | 909,470 | $1.2M | 0.0% | +80,976 |
| Lazard Asset Management LLC | 864,433 | $1.2M | 0.0% | −185,845 |
| OneDigital Investment Advisors LLC | 585,135 | $789.9K | 0.0% | +369,642 |
| WINTON GROUP Ltd | 500,453 | $675.6K | 0.0% | +2,020 |
| State Street Corp | 454,423 | $613.5K | 0.0% | +1,304 |
| Simplex Trading, LLC | 442,677 | $597.6K | 0.0% | +44,743 |
| Group One Trading LLC | 431,853 | $583.0K | 0.0% | +161,926 |
| AdvisorShares Investments LLC | 400,728 | $541.0K | 0.1% | −3,109,133 |
| Dimensional Fund Advisors LP | 328,065 | $442.9K | 0.0% | No change |
| Cable Car Capital, LP | 306,195 | $413.4K | 0.0% | No change |
| BlackRock, Inc. | 301,640 | $407.2K | 0.0% | −19,115 |
| RBF Capital, LLC | 250,000 | $337.5K | 0.0% | No change |
| Baader Bank Aktiengesellschaft | 250,000 | $337.5K | 0.0% | −718 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How SNDL Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSNDL Inc.1
- CIK0001766600
- Filer statusLarge accelerated filer not an emerging growth company1
- Incorporated inA014
- Fiscal year endsDecember 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address17220 Stony Plain Road Nw, Suite 101, Edmonton, Canada (Federal Level)1
- Phone178094499941
- Shares outstanding263,359,123 shares as of Dec 31, 202514
- AuditorCBIZ CPAs P.C. (“CBIZ”), New York, New York, United States PCAOB ID 199; it also attests to the company’s internal control over financial reporting14
- On EDGAR sinceApr 29, 20191
- Filings401 in all: 6-K (289), CORRESP (15), UPLOAD (15), 424B5 (10), EFFECT (9), F-3 (7), S-8 (6), SC 13G/A (5)1
All 33 form types
20-F (4), SC 13G (4), SEC STAFF LETTER (4), 144 (3), 40-F (3), 20-F/A (2), DRS (2), F-1 (2), F-1/A (2), S-8 POS (2), SCHEDULE 13G (2), SCHEDULE 13G/A (2), 424B4 (1), 8-A12B (1), CERT (1), D (1), DRS/A (1), DRSLTR (1), F-1MEF (1), F-3/A (1), F-3MEF (1), F-X (1), FWP (1), POS AM (1), RW (1)
- Latest filingsAnnual report (40-F) Mar 12, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Shares, no par value | SNDL | Nasdaq |
From the cover page of the 40-F filed Mar 12, 2026 (Section 12(b) of the Exchange Act).14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSNDL Inc. filings on SEC EDGAR
- 2
- 3SEC EDGARSNDL Inc. 10-K for fiscal 2025
- 4SEC EDGARSNDL Inc. filings on SEC EDGAR
- 5SEC EDGARSNDL Inc. 10-K for fiscal 2019
- 6SEC EDGARSNDL Inc. 10-K for fiscal 2020
- 7SEC EDGARSNDL Inc. 10-K for fiscal 2022
- 8SEC EDGARSNDL Inc. 10-K for fiscal 2023
- 9SEC EDGARSNDL Inc. 10-K for fiscal 2018
- 10SEC EDGARSNDL Inc. 10-K for fiscal 2019
- 11NasdaqNasdaq calendar
- 12
- 13
- 14